Alpha Cognition (NASDAQ:ACOG) COO Acquires $20,160.00 in Stock

Alpha Cognition Inc. (NASDAQ:ACOG) COO Lauren D’angelo purchased 3,500 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was purchased at an average price of $5.76 per share, for a total transaction of $20,160.00. Following the completion of the acquisition, the chief operating officer owned 140,695 shares of the company’s stock, valued at approximately $810,403.20. This represents a 2.55% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link.

Alpha Cognition Trading Up 0.9%

Shares of Alpha Cognition stock traded up $0.05 during trading on Tuesday, reaching $5.80. The stock had a trading volume of 15,646 shares, compared to its average volume of 61,865. The company has a market capitalization of $126.29 million, a price-to-earnings ratio of -4.30 and a beta of 2.38. The stock has a fifty day moving average price of $6.07 and a two-hundred day moving average price of $5.91. Alpha Cognition Inc. has a 52 week low of $4.50 and a 52 week high of $11.54.

Alpha Cognition (NASDAQ:ACOG) last issued its quarterly earnings results on Thursday, May 14th. The company reported ($0.37) EPS for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.04. The company had revenue of $3.53 million for the quarter, compared to analyst estimates of $3.42 million. Alpha Cognition had a negative return on equity of 58.35% and a negative net margin of 232.23%. On average, equities analysts forecast that Alpha Cognition Inc. will post -1.34 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Aristides Capital LLC grew its stake in Alpha Cognition by 1.4% in the first quarter. Aristides Capital LLC now owns 218,510 shares of the company’s stock valued at $1,200,000 after purchasing an additional 3,052 shares in the last quarter. Ikarian Capital LLC grew its stake in Alpha Cognition by 11.6% in the fourth quarter. Ikarian Capital LLC now owns 1,056,259 shares of the company’s stock valued at $6,866,000 after purchasing an additional 110,000 shares in the last quarter. Sphera Funds Management LTD. grew its stake in Alpha Cognition by 67.6% in the fourth quarter. Sphera Funds Management LTD. now owns 567,616 shares of the company’s stock valued at $3,690,000 after purchasing an additional 228,864 shares in the last quarter. Opaleye Management Inc. grew its stake in Alpha Cognition by 1,698.5% in the fourth quarter. Opaleye Management Inc. now owns 2,070,784 shares of the company’s stock valued at $13,460,000 after purchasing an additional 1,955,642 shares in the last quarter. Finally, ACT Capital Management LLC bought a new position in Alpha Cognition in the fourth quarter valued at approximately $335,000.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Craig Hallum assumed coverage on shares of Alpha Cognition in a research note on Friday, April 17th. They set a “buy” rating and a $14.00 price target for the company. Wall Street Zen cut shares of Alpha Cognition from a “hold” rating to a “sell” rating in a research note on Saturday, May 2nd. Finally, HC Wainwright reissued a “buy” rating and set a $18.00 price target on shares of Alpha Cognition in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, Alpha Cognition currently has a consensus rating of “Buy” and an average price target of $16.00.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.